The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
A Systematic Review of miR-29 in Cancer
Open accessAbstract
MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29's functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–244 of 244
Wang, X., Liu, S., Cao, L., Zhāng, T., Yue, D., Wang, L., Ping, Y., He, Q., Zhang, C., Wang, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21246 · Cited by 72
Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation
Wu, B.-K., & Brenner, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.063 · Cited by 71
McDonald, E. R., & El‐Deiry, W. S. (2001) · Annals of Medicine · doi:10.3109/07853890109002066 · Cited by 70
miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A
Chen, L., Xiao, H., Wang, Z.-H., Huang, Y., Liu, Z.-P., Ren, H. J., & Song, H. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.079 · Cited by 69
Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
Xu, L., Xu, Y., Jing, Z., Wang, X., Zha, X., Zeng, C., Chen, S., Yang, L., Luo, G., Li, B., et al. (2014) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-3-17 · Cited by 69
Cushing, L., Costinean, S., Xu, W. M., Jiang, Z., Madden, L., Kuang, P., Huang, J., Weisman, A. S., Hata, A., Croce, C. M., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005238 · Cited by 65
Hideshima, T., Cottini, F., Ohguchi, H., Jakubíková, J., Görgün, G., Mimura, N., Tai, Y., Munshi, N. C., Richardson, P. G. G., & Anderson, K. C. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.38 · Cited by 65
Wang, D., Fan, Z., Liu, F., & Zuo, J. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438514 · Cited by 65
Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer
Wang, Y., Liu, C., Luo, M., Zhang, Z., Gong, J., Li, J., You, L., Dong, L., Su, R. J., Lin, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-0787 · Cited by 61
Prognostic value of miR-29a expression in pediatric acute myeloid leukemia
Zhu, C., Wang, Y., Kuai, W., Sun, X., Chen, H., & Hong, Z. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.002 · Cited by 61
MiR-29a modulates the angiogenic properties of human endothelial cells
Yang, Z., Wu, L., Zhu, X., Xu, J., Jin, R., Li, G., & Wu, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.054 · Cited by 57
Hepatic mi R ‐29ab1 expression modulates chronic hepatic injury
Kogure, T., Costinean, S., Yan, I. K., Braconi, C., Croce, C. M., & Patel, T. C. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01578.x · Cited by 55
Protein folding, protein homeostasis, and cancer
Drie, J. H. V. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10162 · Cited by 55
Role of the microRNA-29 family in fibrotic skin diseases
Harmancı, D., Erkan, E. P., Koçak, A., & Güner, G. (2017) · Biomedical Reports · doi:10.3892/br.2017.900 · Cited by 55
Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening
Wu, J., Li, L., & Jiang, C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8937-9 · Cited by 54
Wang, H., An, X., Yu, H., Zhang, S., Tang, B., Zhang, X., & Li, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.22183 · Cited by 54
Unicellular origin of the animal microRNA machinery
Bråte, J., Neumann, R. S., Fromm, B., Haraldsen, A. A. B., Tarver, J. E., Suga, H., Donoghue, P. C. J., Peterson, K. J., Ruiz-Trillo, I., Grini, P. E., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.08.018 · Cited by 53
Teng, Y., Zhao, L., Zhang, Y., Chen, W., & Li, X. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358647 · Cited by 53
MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
Sun, X., Liu, B.-Y., Yan, S., Jiang, T., Cheng, H., Jiang, H., Cao, Y., & Mao, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430389 · Cited by 52
Shepard, S. B., Broverman, S., & Muskavitch, M. A. T. (1989) · Genetics · doi:10.1093/genetics/122.2.429 · Cited by 51
Uracils at nucleotide position 9–11 are required for the rapid turnover of miR-29 family
Zhang, Z., Zou, J., Wang, G.-K., Zhang, J.-T., Huang, S., Qin, Y.-W., & Jing, Q. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr020 · Cited by 50
β-catenin downregulates Dicer to promote ovarian cancer metastasis
To, S. K. Y., Mak, A. S. C., Fung, Y. M. E., Che, C., Ss, L., Deng, W., Ru, B., Zhang, J., & Wong, A. S. T. (2017) · Oncogene · doi:10.1038/onc.2017.185 · Cited by 50
Zou, Y., Li, J., Chen, Z., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv027 · Cited by 48
Mazzoccoli, L., Robaina, M. C., Apa, A. G., Bonamino, M., Pinto, L. W., Queiroga, E., Bacchi, C. E., & Klumb, C. E. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2575-3 · Cited by 48
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
Duhachek-Muggy, S., & Żółkiewska, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1108-1 · Cited by 47
Zhang, L., Ye, Y., Tu, H., Hildebrandt, M. A. T., Zhao, L., Heymach, J. V., Roth, J. A., & Wu, X. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx046 · Cited by 46
Baldwin, A. E., Li, W., Grace, M. R., Pearlberg, J., Harlow, E., Münger, K., & Grueneberg, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806195105 · Cited by 45
MiR-29 family members interact with SPARC to regulate glucose metabolism
Song, H., Ding, L., Zhang, S., & Wang, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.129 · Cited by 44
Joerger, M., Baty, F., Früh, M., Droege, C., Stahel, R. A., Betticher, D. C., von Moos, R., Ochsenbein, A. F., Pless, M., Gautschi, O. P., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.014 · Cited by 42
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
Muluhngwi, P., Alizadeh‐Rad, N., Vittitow, S. L., Kalbfleisch, T., & Klinge, C. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-05727-w · Cited by 40
miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs
Cui, Y., Li, T., Yang, D., Li, S., & Le, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10751 · Cited by 36
Wang, F., Ma, H., Liang, W., Yang, J., Wang, X.-Q., Shan, M., Chen, Y., Jia, M., Yin, Y., Sun, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14462 · Cited by 35
Spender, L. C., Carter, M. J., O’Brien, D. I., Clark, L., Yu, J., Michalak, E. M., Happo, L., Cragg, M. S., & Inman, G. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410274 · Cited by 33
MiR-29a and miR-652 Attenuate Liver Fibrosis by Inhibiting the Differentiation of CD4+ T Cells
Xuan, J., Guo, S., Huang, A., Xu, H.-B., Shao, M., Yang, Y., & Wen, W. (2017) · Cell Structure and Function · doi:10.1247/csf.17005 · Cited by 31
Francy, J. M., Nag, A., Conroy, E. J., Hengst, J. A., & Yun, J. K. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.03.005 · Cited by 29
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3
Young, C. D., Nolte, E., Lewis, A. S., Serkova, N. J., & Anderson, S. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2132 · Cited by 29
miR-29a regulates the proliferation and differentiation of retinal progenitors by targeting Rbm8a
Zhang, Y., Shen, B., Zhang, D., Wang, Y., Tang, Z., Ni, N., Jin, X., Luo, M., Sun, H., & Gu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.16669 · Cited by 29
Fu, Q., Shi, H., Ni, W., Shi, M., Meng, L., Zhang, H., Ren, Y., Guo, F., Wang, P., Qiao, J., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.067140-0 · Cited by 27
Liu, Y., CHEN, X., Gu, Y., Zhu, L., Qian, Y., PEI, D., ZHANG, W., & Shu, Y. (2015) · Neoplasma · doi:10.4149/neo_2015_008 · Cited by 25
Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
Wang, J., Yu, H., Ye, L., Jin, L., Yu, M., & Lv, Y. (2015) · Europe PMC (PubMed Central) · Cited by 23
Regulation of type I collagen expression by microRNA-29 following ionizing radiation
Yano, H., Hamanaka, R., Nakamura-Ota, M., Zhang, J. J., Matsuo, N., & Yoshioka, H. (2017) · Radiation and Environmental Biophysics · doi:10.1007/s00411-017-0723-4 · Cited by 18
microRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymoma
Lourdusamy, A., Rahman, R., Smith, S. J., & Grundy, R. G. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0206-2 · Cited by 11
Role of miR-29 as marker of risk of acute rejection after heart transplant
Guo, S., Guo, X., Wang, S., Nie, Q., Ni, G., & Wang, C. (2017) · British Journal of Biomedical Science · doi:10.1080/09674845.2017.1333265 · Cited by 11
Integrated miRNA-mRNA analysis of Epstein-Barr virus-positive nasopharyngeal carcinoma
Zhu, L., Miao, X. T., & Wang, N. (2015) · Genetics and Molecular Research · doi:10.4238/2015.june.1.20 · Cited by 8
Cited by
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
McCubrey, J. A., Yang, L. V., Abrams, S. L., Steelman, L. S., Follo, M. Y., Cocco, L., Ratti, S., Martelli, A. M., Augello, G., & Cervello, M. (2022) · Cells · doi:10.3390/cells11142155 · Cited by 49
“TP53 can induce the expression of miR-29 in certain cancers [34,39].”
BackgroundWalsh, A. D., Stone, S., Freytag, S., Aprico, A., Kilpatrick, T. J., Ansell, B. R. E., & Binder, M. D. (2023) · Communications Biology · doi:10.1038/s42003-023-04926-8 · Cited by 9
Metadata
- Authors
- Kwon, J. J., Factora, T. D., Dey, S., & Kota, J.
- Venue
- Molecular Therapy Oncolytics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 12
- Pages
- 173-194
- ISSN
- 2372-7705 (ISSN-L)
- OpenAlex
- W2907841219
- Cited by
- 263
- References
- 244
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.